A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Chiara R. Dart(University of Colorado Anschutz Medical Campus), Yiqun G. Shellman(University of Colorado Anschutz Medical Campus)
Cited by 5
Related Papers
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
|Cell Death and Disease|2020|71
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
|Cell Death and Disease|2018|27